Title: Wall St eyes dour open as Omicron worries grow after vaccine warning
- analysiswatch
- Nov 30, 2021
- 2 min read

Nov 30, 2021 08:48AM ET
By: AnalysisWatch
Wall Street's significant lists were set to fall strongly on Tuesday after a notice from the CEO of immunization producer Moderna on the efficacy of the COVID-19 vaccine against the Omicron variant pressured stocks in the travel, energy, and banking sectors.
Worldwide securities exchanges plunged after Moderna CEO Stéphane Bancel told the Financial Times almost certainly, the current age antibody would be changed.
Fears were heightened when Regeneron Pharmaceuticals Inc. said its Coronavirus immunizer treatment and other comparative medications might be less powerful against the Omicron variation.
Occidental Petroleum drove the misfortunes among energy stocks, with its portions falling 3.5% in premarket exchanging, while oil costs drooped almost 3% on-request concerns.
Money Street's enormous loan specialists slipped, following a drop in Treasury yields as a place of refuge request kept security buys high. Bank of America was the biggest loser among public companies, down 2%.
Among aircraft stocks, which fell somewhere in the range of 1.5% and 1.9%, American Airlines Group fell the most. Cruise companies Carnival Corp, Royal Caribbean, and Norwegian Cruise Line each lost about 2 %.
The S&P 500 and the tech-heavy Nasdaq are down 1.9% and 2.7%, respectively, from their record highs, reached earlier this month, while the Dow has fallen 3.9%.
At 10 a.m. ET (1500 GMT), Treasury Secretary Janet Yellen, and Federal Reserve Chairman Jerome Powell will testify before the US Senate Banking Committee at 10 a.m. ET (1500 GMT) to discuss the economic recovery from the pandemic.
In his prepared remarks, Powell said he still expects inflation to fall next year, but warned that the new variant of COVID-19 clouds the outlook, and prices could rise for longer than previously thought.
Comments